Although large studies of the COVID-19 and shingles vaccines found few risks and overall safety, the U.S. Food and Drug Administration has blocked their publication, even as millions of dollars in taxpayer money was spent on them.
Critics believe the studies weren’t blocked because they were flawed, but rather because they found value in the vaccines.
The shingles and COVID vaccine studies in question were conducted by federal employee scientists who looked at millions of patient records and only rarely found serious side effects ….
Reuters reported that the “withdrawal of these studies is the latest attempt by the health regulator and the administration to limit access to vaccines, reflecting broader policy changes under U.S. Health Services Secretary Robert F. Kennedy Jr., a staunch critic of vaccines.”
…
…[T]his batch of studies isn’t the first denied publication. … [T]he Centers for Disease Control and Prevention opted not to publish a study that found the COVID-19 vaccine cut the likelihood of needing to be hospitalized last winter and also reduced emergency department visits.















